Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models.

Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models.

<h4>Background</h4>Although genotypic resistance testing (GRT) is recommended to guide combination antiretroviral therapy (cART), funding and/or facilities to perform GRT may not be available in low to middle income countries. Since treatment history (TH) impacts response to subsequent t...

Full description

Bibliographic Details
Main Authors: Mattia C F Prosperi, Michal Rosen-Zvi, André Altmann, Maurizio Zazzi, Simona Di Giambenedetto, Rolf Kaiser, Eugen Schülter, Daniel Struck, Peter Sloot, David A van de Vijver, Anne-Mieke Vandamme, Anders Sönnerborg, EuResist study group, Virolab study group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-10-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21060792/pdf/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21060792/pdf/?tool=EBI

Similar Items